Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/16160
Title: A safe and effective consecutive-infusion regimen for rapid quinine loading in severe falciparum malaria
Authors: Timothy M.E. Davis
Wichai Supanaranond
Sasithon Pukrittayakamee
Juntra Karbwang
Pidist Molunto
Sopon Mekthon
Nicholas J. White
Mahidol University
Paholpolpayuhasena Hospital
John Radcliffe Hospital
Keywords: Medicine
Issue Date: 1-Jan-1990
Citation: Journal of Infectious Diseases. Vol.161, No.6 (1990), 1305-1308
Abstract: Recommended initial treatment of severe chloroquine-resistant falciparum malaria consists of a 4-h loading infusion of20 mg of quinine dihydrochloride (salt)/kg of body weight. Toachieve and maintain therapeutic blood quinine concentrations (10mg/l) safely and rapidly, a consecutive-infusion regimen (7 mg of salt/kg of body weight over 30 min followed by 10 mg of salt/kg of body weight over 4 h) based on pharmacokinetic parameters in cerebral malaria has been suggested. This regimen was evaluated in 16 adults (6 male, 10 female; mean age, 25.9 years) with severe falciparum malaria. Plasma quinine concentrations (mean ± SE) were 8.7 ± 1.2 mg/l at 30 min and 11.0 ± 1.8mg/l at 4.5 h. There was no electrocardiographic evidence of serious cardiotoxicity during the 4.5-h infusion period, and systolic blood pressure fell by > 10 mm Hg in only one patient. Parasite clearance in 13 surviving patients (median count on admission, 438 * 10 3 /μl; range, 500-122 * 10 4 ) took an average of 71 h (range, 9-115). This regimen is safe, effective, and suitable for use in an intensive care unit. © 1990, University of Chicago. All rights reserved.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0025339526&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/16160
ISSN: 15376613
00221899
Appears in Collections:Scopus 1969-1990

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.